nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCG2—Glyburide—gestational diabetes	0.186	0.324	CbGbCtD
Imatinib—ALB—Glyburide—gestational diabetes	0.128	0.223	CbGbCtD
Imatinib—CYP2C19—Glyburide—gestational diabetes	0.0832	0.145	CbGbCtD
Imatinib—CYP2C9—Glyburide—gestational diabetes	0.0692	0.12	CbGbCtD
Imatinib—ABCB1—Glyburide—gestational diabetes	0.0672	0.117	CbGbCtD
Imatinib—CYP3A4—Glyburide—gestational diabetes	0.0402	0.07	CbGbCtD
Imatinib—Hypotrichosis—Glyburide—gestational diabetes	0.0388	0.197	CcSEcCtD
Imatinib—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.0115	0.0584	CcSEcCtD
Imatinib—Hepatitis cholestatic—Glyburide—gestational diabetes	0.00907	0.0461	CcSEcCtD
Imatinib—Myelosuppression—Glyburide—gestational diabetes	0.00779	0.0396	CcSEcCtD
Imatinib—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.00745	0.0378	CcSEcCtD
Imatinib—ABCA3—islet of Langerhans—gestational diabetes	0.0066	0.045	CbGeAlD
Imatinib—DDR1—islet of Langerhans—gestational diabetes	0.00609	0.0415	CbGeAlD
Imatinib—Drug eruption—Glyburide—gestational diabetes	0.00594	0.0302	CcSEcCtD
Imatinib—Digestion impaired—Glyburide—gestational diabetes	0.00547	0.0278	CcSEcCtD
Imatinib—Heartburn—Glyburide—gestational diabetes	0.00531	0.027	CcSEcCtD
Imatinib—ABCA3—adipose tissue—gestational diabetes	0.00421	0.0287	CbGeAlD
Imatinib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00402	0.0204	CcSEcCtD
Imatinib—DDR1—uterus—gestational diabetes	0.00397	0.0271	CbGeAlD
Imatinib—DDR1—adipose tissue—gestational diabetes	0.00388	0.0265	CbGeAlD
Imatinib—PIP4K2C—islet of Langerhans—gestational diabetes	0.00376	0.0256	CbGeAlD
Imatinib—Vasculitis—Glyburide—gestational diabetes	0.00374	0.019	CcSEcCtD
Imatinib—ABCA3—vagina—gestational diabetes	0.0035	0.0238	CbGeAlD
Imatinib—CA9—islet of Langerhans—gestational diabetes	0.00344	0.0234	CbGeAlD
Imatinib—Aplastic anaemia—Glyburide—gestational diabetes	0.00343	0.0174	CcSEcCtD
Imatinib—ABCA3—head—gestational diabetes	0.00323	0.022	CbGeAlD
Imatinib—DDR1—vagina—gestational diabetes	0.00323	0.022	CbGeAlD
Imatinib—Vascular purpura—Glyburide—gestational diabetes	0.00297	0.0151	CcSEcCtD
Imatinib—Deafness—Glyburide—gestational diabetes	0.00297	0.0151	CcSEcCtD
Imatinib—Hepatic failure—Glyburide—gestational diabetes	0.00295	0.015	CcSEcCtD
Imatinib—Haemolytic anaemia—Glyburide—gestational diabetes	0.00294	0.0149	CcSEcCtD
Imatinib—Renal failure acute—Glyburide—gestational diabetes	0.00287	0.0146	CcSEcCtD
Imatinib—Dermatitis bullous—Glyburide—gestational diabetes	0.00278	0.0141	CcSEcCtD
Imatinib—NQO2—islet of Langerhans—gestational diabetes	0.00276	0.0188	CbGeAlD
Imatinib—Purpura—Glyburide—gestational diabetes	0.00275	0.014	CcSEcCtD
Imatinib—Arthritis—Glyburide—gestational diabetes	0.00273	0.0139	CcSEcCtD
Imatinib—Hypoglycaemia—Glyburide—gestational diabetes	0.00272	0.0138	CcSEcCtD
Imatinib—Hyponatraemia—Glyburide—gestational diabetes	0.00266	0.0135	CcSEcCtD
Imatinib—PDGFRA—embryo—gestational diabetes	0.00266	0.0181	CbGeAlD
Imatinib—ABL2—adipose tissue—gestational diabetes	0.00253	0.0173	CbGeAlD
Imatinib—PIP4K2C—adipose tissue—gestational diabetes	0.0024	0.0163	CbGeAlD
Imatinib—CSF1R—embryo—gestational diabetes	0.00235	0.016	CbGeAlD
Imatinib—CA3—uterus—gestational diabetes	0.00234	0.0159	CbGeAlD
Imatinib—Abdominal distension—Glyburide—gestational diabetes	0.00231	0.0117	CcSEcCtD
Imatinib—CA3—adipose tissue—gestational diabetes	0.00229	0.0156	CbGeAlD
Imatinib—Eosinophilia—Glyburide—gestational diabetes	0.00227	0.0115	CcSEcCtD
Imatinib—Pancreatitis—Glyburide—gestational diabetes	0.00225	0.0114	CcSEcCtD
Imatinib—Sweating increased—Glyburide—gestational diabetes	0.00223	0.0113	CcSEcCtD
Imatinib—Pancytopenia—Glyburide—gestational diabetes	0.00218	0.0111	CcSEcCtD
Imatinib—LCK—uterus—gestational diabetes	0.00218	0.0148	CbGeAlD
Imatinib—PDGFRB—islet of Langerhans—gestational diabetes	0.00215	0.0146	CbGeAlD
Imatinib—KIT—embryo—gestational diabetes	0.00213	0.0145	CbGeAlD
Imatinib—LCK—adipose tissue—gestational diabetes	0.00213	0.0145	CbGeAlD
Imatinib—ABL2—vagina—gestational diabetes	0.00211	0.0143	CbGeAlD
Imatinib—Photosensitivity reaction—Glyburide—gestational diabetes	0.00209	0.0106	CcSEcCtD
Imatinib—PDGFRB—embryo—gestational diabetes	0.00208	0.0142	CbGeAlD
Imatinib—PIP4K2C—vagina—gestational diabetes	0.00199	0.0136	CbGeAlD
Imatinib—Jaundice—Glyburide—gestational diabetes	0.00199	0.0101	CcSEcCtD
Imatinib—ABL1—islet of Langerhans—gestational diabetes	0.00192	0.0131	CbGeAlD
Imatinib—Agranulocytosis—Glyburide—gestational diabetes	0.00191	0.00969	CcSEcCtD
Imatinib—CA3—vagina—gestational diabetes	0.0019	0.013	CbGeAlD
Imatinib—CA6—head—gestational diabetes	0.00186	0.0126	CbGeAlD
Imatinib—ABL1—embryo—gestational diabetes	0.00185	0.0126	CbGeAlD
Imatinib—PIP4K2C—head—gestational diabetes	0.00184	0.0125	CbGeAlD
Imatinib—Hepatitis—Glyburide—gestational diabetes	0.00184	0.00932	CcSEcCtD
Imatinib—NQO2—uterus—gestational diabetes	0.0018	0.0123	CbGeAlD
Imatinib—PDGFRA—uterus—gestational diabetes	0.0018	0.0122	CbGeAlD
Imatinib—LCK—vagina—gestational diabetes	0.00177	0.0121	CbGeAlD
Imatinib—NQO2—adipose tissue—gestational diabetes	0.00176	0.012	CbGeAlD
Imatinib—CA3—head—gestational diabetes	0.00176	0.012	CbGeAlD
Imatinib—PDGFRA—adipose tissue—gestational diabetes	0.00176	0.012	CbGeAlD
Imatinib—Eye disorder—Glyburide—gestational diabetes	0.00172	0.00871	CcSEcCtD
Imatinib—Alopecia—Glyburide—gestational diabetes	0.00162	0.00824	CcSEcCtD
Imatinib—Malnutrition—Glyburide—gestational diabetes	0.0016	0.00811	CcSEcCtD
Imatinib—Erythema—Glyburide—gestational diabetes	0.0016	0.00811	CcSEcCtD
Imatinib—CSF1R—uterus—gestational diabetes	0.00158	0.0108	CbGeAlD
Imatinib—CSF1R—adipose tissue—gestational diabetes	0.00155	0.0105	CbGeAlD
Imatinib—Vision blurred—Glyburide—gestational diabetes	0.00151	0.00765	CcSEcCtD
Imatinib—Tremor—Glyburide—gestational diabetes	0.0015	0.0076	CcSEcCtD
Imatinib—Anaemia—Glyburide—gestational diabetes	0.00148	0.0075	CcSEcCtD
Imatinib—NQO2—vagina—gestational diabetes	0.00146	0.00997	CbGeAlD
Imatinib—PDGFRA—vagina—gestational diabetes	0.00146	0.00995	CbGeAlD
Imatinib—Angioedema—Glyburide—gestational diabetes	0.00146	0.00741	CcSEcCtD
Imatinib—SLC47A1—uterus—gestational diabetes	0.00144	0.00984	CbGeAlD
Imatinib—KIT—uterus—gestational diabetes	0.00144	0.00978	CbGeAlD
Imatinib—Leukopenia—Glyburide—gestational diabetes	0.00143	0.00726	CcSEcCtD
Imatinib—SLC47A1—adipose tissue—gestational diabetes	0.00141	0.00962	CbGeAlD
Imatinib—KIT—adipose tissue—gestational diabetes	0.0014	0.00956	CbGeAlD
Imatinib—PDGFRB—uterus—gestational diabetes	0.0014	0.00955	CbGeAlD
Imatinib—Convulsion—Glyburide—gestational diabetes	0.00138	0.00703	CcSEcCtD
Imatinib—PDGFRB—adipose tissue—gestational diabetes	0.00137	0.00934	CbGeAlD
Imatinib—Arthralgia—Glyburide—gestational diabetes	0.00136	0.00691	CcSEcCtD
Imatinib—Myalgia—Glyburide—gestational diabetes	0.00136	0.00691	CcSEcCtD
Imatinib—NQO2—head—gestational diabetes	0.00135	0.00921	CbGeAlD
Imatinib—PDGFRA—head—gestational diabetes	0.00135	0.00919	CbGeAlD
Imatinib—Confusional state—Glyburide—gestational diabetes	0.00131	0.00668	CcSEcCtD
Imatinib—CA2—islet of Langerhans—gestational diabetes	0.00131	0.00889	CbGeAlD
Imatinib—Oedema—Glyburide—gestational diabetes	0.0013	0.00662	CcSEcCtD
Imatinib—CSF1R—vagina—gestational diabetes	0.00129	0.00876	CbGeAlD
Imatinib—CA1—adipose tissue—gestational diabetes	0.00128	0.00875	CbGeAlD
Imatinib—Shock—Glyburide—gestational diabetes	0.00128	0.00651	CcSEcCtD
Imatinib—Nervous system disorder—Glyburide—gestational diabetes	0.00128	0.00649	CcSEcCtD
Imatinib—Thrombocytopenia—Glyburide—gestational diabetes	0.00128	0.00648	CcSEcCtD
Imatinib—CA2—embryo—gestational diabetes	0.00126	0.0086	CbGeAlD
Imatinib—Hyperhidrosis—Glyburide—gestational diabetes	0.00126	0.0064	CcSEcCtD
Imatinib—ABL1—uterus—gestational diabetes	0.00125	0.00851	CbGeAlD
Imatinib—CA12—head—gestational diabetes	0.00125	0.00848	CbGeAlD
Imatinib—Anorexia—Glyburide—gestational diabetes	0.00124	0.00631	CcSEcCtD
Imatinib—ABL1—adipose tissue—gestational diabetes	0.00122	0.00833	CbGeAlD
Imatinib—Hypotension—Glyburide—gestational diabetes	0.00122	0.00619	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00119	0.00603	CcSEcCtD
Imatinib—CSF1R—head—gestational diabetes	0.00119	0.00809	CbGeAlD
Imatinib—SLC22A1—adipose tissue—gestational diabetes	0.00118	0.00803	CbGeAlD
Imatinib—SLC47A1—vagina—gestational diabetes	0.00117	0.008	CbGeAlD
Imatinib—Paraesthesia—Glyburide—gestational diabetes	0.00117	0.00595	CcSEcCtD
Imatinib—KIT—vagina—gestational diabetes	0.00117	0.00795	CbGeAlD
Imatinib—Dyspnoea—Glyburide—gestational diabetes	0.00116	0.0059	CcSEcCtD
Imatinib—Dyspepsia—Glyburide—gestational diabetes	0.00115	0.00583	CcSEcCtD
Imatinib—PDGFRB—vagina—gestational diabetes	0.00114	0.00777	CbGeAlD
Imatinib—Decreased appetite—Glyburide—gestational diabetes	0.00113	0.00576	CcSEcCtD
Imatinib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00113	0.00572	CcSEcCtD
Imatinib—CYP3A5—islet of Langerhans—gestational diabetes	0.00112	0.00764	CbGeAlD
Imatinib—SLC47A1—head—gestational diabetes	0.00108	0.00739	CbGeAlD
Imatinib—KIT—head—gestational diabetes	0.00108	0.00734	CbGeAlD
Imatinib—Feeling abnormal—Glyburide—gestational diabetes	0.00107	0.00546	CcSEcCtD
Imatinib—Gastrointestinal pain—Glyburide—gestational diabetes	0.00107	0.00541	CcSEcCtD
Imatinib—PDGFRB—head—gestational diabetes	0.00105	0.00717	CbGeAlD
Imatinib—Urticaria—Glyburide—gestational diabetes	0.00104	0.00526	CcSEcCtD
Imatinib—Abdominal pain—Glyburide—gestational diabetes	0.00103	0.00523	CcSEcCtD
Imatinib—ABL1—vagina—gestational diabetes	0.00102	0.00692	CbGeAlD
Imatinib—CA1—head—gestational diabetes	0.000986	0.00672	CbGeAlD
Imatinib—SLC22A1—vagina—gestational diabetes	0.00098	0.00667	CbGeAlD
Imatinib—Hypersensitivity—Glyburide—gestational diabetes	0.000961	0.00488	CcSEcCtD
Imatinib—ABL1—head—gestational diabetes	0.000939	0.00639	CbGeAlD
Imatinib—Asthenia—Glyburide—gestational diabetes	0.000936	0.00475	CcSEcCtD
Imatinib—Pruritus—Glyburide—gestational diabetes	0.000923	0.00468	CcSEcCtD
Imatinib—SLC22A1—head—gestational diabetes	0.000905	0.00616	CbGeAlD
Imatinib—Diarrhoea—Glyburide—gestational diabetes	0.000892	0.00453	CcSEcCtD
Imatinib—CA2—adipose tissue—gestational diabetes	0.000832	0.00567	CbGeAlD
Imatinib—Vomiting—Glyburide—gestational diabetes	0.000829	0.00421	CcSEcCtD
Imatinib—Rash—Glyburide—gestational diabetes	0.000822	0.00418	CcSEcCtD
Imatinib—Dermatitis—Glyburide—gestational diabetes	0.000821	0.00417	CcSEcCtD
Imatinib—Headache—Glyburide—gestational diabetes	0.000817	0.00415	CcSEcCtD
Imatinib—ABCG2—uterus—gestational diabetes	0.000788	0.00537	CbGeAlD
Imatinib—Nausea—Glyburide—gestational diabetes	0.000775	0.00393	CcSEcCtD
Imatinib—ABCG2—adipose tissue—gestational diabetes	0.000771	0.00525	CbGeAlD
Imatinib—CYP2C19—vagina—gestational diabetes	0.000755	0.00514	CbGeAlD
Imatinib—CYP3A5—adipose tissue—gestational diabetes	0.000716	0.00487	CbGeAlD
Imatinib—CA2—vagina—gestational diabetes	0.000692	0.00471	CbGeAlD
Imatinib—PTGS1—uterus—gestational diabetes	0.000657	0.00448	CbGeAlD
Imatinib—PTGS1—adipose tissue—gestational diabetes	0.000643	0.00438	CbGeAlD
Imatinib—ABCG2—vagina—gestational diabetes	0.000641	0.00436	CbGeAlD
Imatinib—CA2—head—gestational diabetes	0.000639	0.00435	CbGeAlD
Imatinib—ABCB1—islet of Langerhans—gestational diabetes	0.000596	0.00406	CbGeAlD
Imatinib—CYP3A5—vagina—gestational diabetes	0.000595	0.00405	CbGeAlD
Imatinib—ABCB1—embryo—gestational diabetes	0.000576	0.00393	CbGeAlD
Imatinib—PTGS1—vagina—gestational diabetes	0.000535	0.00364	CbGeAlD
Imatinib—PTGS1—head—gestational diabetes	0.000494	0.00336	CbGeAlD
Imatinib—CYP2D6—head—gestational diabetes	0.000406	0.00276	CbGeAlD
Imatinib—ABCB1—uterus—gestational diabetes	0.000389	0.00265	CbGeAlD
Imatinib—ABCB1—adipose tissue—gestational diabetes	0.00038	0.00259	CbGeAlD
Imatinib—ABCB1—vagina—gestational diabetes	0.000316	0.00215	CbGeAlD
Imatinib—ABCB1—head—gestational diabetes	0.000292	0.00199	CbGeAlD
Imatinib—PDGFRA—Signaling by ERBB2—FGF2—gestational diabetes	0.000168	0.00205	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 signaling—FGF2—gestational diabetes	0.000167	0.00204	CbGpPWpGaD
Imatinib—KIT—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000166	0.00203	CbGpPWpGaD
Imatinib—KIT—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000166	0.00203	CbGpPWpGaD
Imatinib—KIT—DAP12 interactions—FGF2—gestational diabetes	0.000166	0.00203	CbGpPWpGaD
Imatinib—CA7—Metabolism—NAMPT—gestational diabetes	0.000165	0.00202	CbGpPWpGaD
Imatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000165	0.00201	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR—FGF2—gestational diabetes	0.000165	0.00201	CbGpPWpGaD
Imatinib—CA7—Metabolism—GCK—gestational diabetes	0.000164	0.00201	CbGpPWpGaD
Imatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000164	0.002	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000163	0.00199	CbGpPWpGaD
Imatinib—PDGFRB—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000162	0.00199	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000162	0.00199	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—FGF2—gestational diabetes	0.000162	0.00199	CbGpPWpGaD
Imatinib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000162	0.00198	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—FGF2—gestational diabetes	0.00016	0.00196	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—MBL2—gestational diabetes	0.000158	0.00193	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000157	0.00192	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 interactions—FGF2—gestational diabetes	0.000157	0.00192	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000157	0.00192	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—GCK—gestational diabetes	0.000156	0.00191	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—FGF2—gestational diabetes	0.000156	0.0019	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000154	0.00189	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—FGF2—gestational diabetes	0.000154	0.00189	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—FGF2—gestational diabetes	0.000154	0.00188	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—FGF2—gestational diabetes	0.000154	0.00188	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—MBL2—gestational diabetes	0.000154	0.00188	CbGpPWpGaD
Imatinib—CA12—Metabolism—NAMPT—gestational diabetes	0.000153	0.00187	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—FGF2—gestational diabetes	0.000153	0.00187	CbGpPWpGaD
Imatinib—CA12—Metabolism—GCK—gestational diabetes	0.000152	0.00186	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR—FGF2—gestational diabetes	0.000152	0.00186	CbGpPWpGaD
Imatinib—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.000152	0.00186	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—FGF2—gestational diabetes	0.000151	0.00185	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—FGF2—gestational diabetes	0.00015	0.00184	CbGpPWpGaD
Imatinib—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00015	0.00183	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000148	0.00181	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000148	0.00181	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000147	0.0018	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—FGF2—gestational diabetes	0.000145	0.00178	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000144	0.00176	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—FGF2—gestational diabetes	0.000142	0.00173	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000142	0.00173	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000142	0.00173	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—FGF2—gestational diabetes	0.00014	0.00172	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000139	0.0017	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000139	0.0017	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—FGF2—gestational diabetes	0.000138	0.00169	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000136	0.00167	CbGpPWpGaD
Imatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000133	0.00163	CbGpPWpGaD
Imatinib—CA14—Metabolism—CYP19A1—gestational diabetes	0.000132	0.00161	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—FGF2—gestational diabetes	0.000131	0.0016	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00013	0.00159	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.00013	0.00159	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.00013	0.00159	CbGpPWpGaD
Imatinib—CA6—Metabolism—CYP19A1—gestational diabetes	0.000129	0.00157	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—ADIPOQ—gestational diabetes	0.000129	0.00157	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000129	0.00157	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—FGF2—gestational diabetes	0.000128	0.00157	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—MBL2—gestational diabetes	0.000126	0.00155	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000125	0.00153	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—LEPR—gestational diabetes	0.000124	0.00152	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—FGF2—gestational diabetes	0.000123	0.0015	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—FGF2—gestational diabetes	0.000122	0.00149	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—FGF2—gestational diabetes	0.000121	0.00148	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—FGF2—gestational diabetes	0.000121	0.00148	CbGpPWpGaD
Imatinib—CA7—Metabolism—CYP19A1—gestational diabetes	0.00012	0.00147	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000119	0.00146	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000117	0.00144	CbGpPWpGaD
Imatinib—CA2—Metabolism—NAMPT—gestational diabetes	0.000117	0.00143	CbGpPWpGaD
Imatinib—CA2—Metabolism—GCK—gestational diabetes	0.000116	0.00142	CbGpPWpGaD
Imatinib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000116	0.00142	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000114	0.00139	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—FGF2—gestational diabetes	0.000114	0.00139	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000114	0.00139	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000113	0.00138	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000113	0.00138	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—FGF2—gestational diabetes	0.000113	0.00138	CbGpPWpGaD
Imatinib—CA1—Metabolism—NAMPT—gestational diabetes	0.000112	0.00137	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000112	0.00137	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000112	0.00136	CbGpPWpGaD
Imatinib—CA1—Metabolism—GCK—gestational diabetes	0.000112	0.00136	CbGpPWpGaD
Imatinib—CA12—Metabolism—CYP19A1—gestational diabetes	0.000111	0.00136	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—FGF2—gestational diabetes	0.000111	0.00136	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000108	0.00132	CbGpPWpGaD
Imatinib—KIT—Immune System—MBL2—gestational diabetes	0.000108	0.00132	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000107	0.00131	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000107	0.00131	CbGpPWpGaD
Imatinib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000106	0.0013	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000106	0.00129	CbGpPWpGaD
Imatinib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000106	0.00129	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—FGF2—gestational diabetes	0.000105	0.00129	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000105	0.00128	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—TNF—gestational diabetes	0.000105	0.00128	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000104	0.00127	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GGCT—gestational diabetes	0.000103	0.00126	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GGCT—gestational diabetes	0.000103	0.00126	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000102	0.00125	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000102	0.00125	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000101	0.00123	CbGpPWpGaD
Imatinib—KIT—Disease—RBP4—gestational diabetes	0.0001	0.00122	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GGCT—gestational diabetes	0.0001	0.00122	CbGpPWpGaD
Imatinib—CA9—Metabolism—NAMPT—gestational diabetes	9.87e-05	0.00121	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MTNR1B—gestational diabetes	9.82e-05	0.0012	CbGpPWpGaD
Imatinib—CA9—Metabolism—GCK—gestational diabetes	9.81e-05	0.0012	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—GCK—gestational diabetes	9.76e-05	0.00119	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	9.64e-05	0.00118	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GGCT—gestational diabetes	9.61e-05	0.00117	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RBP4—gestational diabetes	9.57e-05	0.00117	CbGpPWpGaD
Imatinib—PDGFRA—Disease—RBP4—gestational diabetes	9.48e-05	0.00116	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MBL2—gestational diabetes	9.18e-05	0.00112	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	9.15e-05	0.00112	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TNF—gestational diabetes	9.11e-05	0.00111	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—LEPR—gestational diabetes	9.1e-05	0.00111	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GLS2—gestational diabetes	9.1e-05	0.00111	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GLS2—gestational diabetes	9.02e-05	0.0011	CbGpPWpGaD
Imatinib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	9.02e-05	0.0011	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GLS2—gestational diabetes	9.01e-05	0.0011	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9e-05	0.0011	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	8.99e-05	0.0011	CbGpPWpGaD
Imatinib—KIT—Disease—NAMPT—gestational diabetes	8.98e-05	0.0011	CbGpPWpGaD
Imatinib—ABL1—Immune System—MBL2—gestational diabetes	8.94e-05	0.00109	CbGpPWpGaD
Imatinib—KIT—Disease—GCK—gestational diabetes	8.93e-05	0.00109	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GLS2—gestational diabetes	8.75e-05	0.00107	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	8.62e-05	0.00105	CbGpPWpGaD
Imatinib—PDGFRB—Disease—RBP4—gestational diabetes	8.54e-05	0.00104	CbGpPWpGaD
Imatinib—CA2—Metabolism—CYP19A1—gestational diabetes	8.51e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NAMPT—gestational diabetes	8.5e-05	0.00104	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	8.5e-05	0.00104	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.5e-05	0.00104	CbGpPWpGaD
Imatinib—PDGFRA—Disease—GCK—gestational diabetes	8.45e-05	0.00103	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GLS2—gestational diabetes	8.4e-05	0.00103	CbGpPWpGaD
Imatinib—CA1—Metabolism—CYP19A1—gestational diabetes	8.16e-05	0.000998	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—LEP—gestational diabetes	7.99e-05	0.000977	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.91e-05	0.000967	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.82e-05	0.000956	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	7.76e-05	0.00095	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—FGF2—gestational diabetes	7.74e-05	0.000947	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NAMPT—gestational diabetes	7.66e-05	0.000937	CbGpPWpGaD
Imatinib—PDGFRB—Disease—GCK—gestational diabetes	7.61e-05	0.000931	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGCT—gestational diabetes	7.46e-05	0.000913	CbGpPWpGaD
Imatinib—LCK—Immune System—MBL2—gestational diabetes	7.36e-05	0.000901	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—TNF—gestational diabetes	7.23e-05	0.000885	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	7.2e-05	0.00088	CbGpPWpGaD
Imatinib—CA9—Metabolism—CYP19A1—gestational diabetes	7.17e-05	0.000877	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.06e-05	0.000863	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RBP4—gestational diabetes	7.01e-05	0.000858	CbGpPWpGaD
Imatinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	6.96e-05	0.000851	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—TNF—gestational diabetes	6.91e-05	0.000845	CbGpPWpGaD
Imatinib—LCK—Disease—RBP4—gestational diabetes	6.85e-05	0.000838	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	6.81e-05	0.000833	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	6.64e-05	0.000812	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—GCK—gestational diabetes	6.53e-05	0.000799	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GLS2—gestational diabetes	6.52e-05	0.000798	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—FGF2—gestational diabetes	6.45e-05	0.000789	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGCT—gestational diabetes	6.43e-05	0.000786	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LEPR—gestational diabetes	6.23e-05	0.000762	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—FGF2—gestational diabetes	6.19e-05	0.000758	CbGpPWpGaD
Imatinib—LCK—Disease—NAMPT—gestational diabetes	6.15e-05	0.000752	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	6.14e-05	0.000751	CbGpPWpGaD
Imatinib—LCK—Disease—GCK—gestational diabetes	6.11e-05	0.000747	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	6.11e-05	0.000747	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—FGF2—gestational diabetes	6.07e-05	0.000742	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	5.98e-05	0.000732	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	5.86e-05	0.000717	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGCT—gestational diabetes	5.77e-05	0.000706	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	5.72e-05	0.0007	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGCT—gestational diabetes	5.63e-05	0.000689	CbGpPWpGaD
Imatinib—ALB—Metabolism—GLS2—gestational diabetes	5.62e-05	0.000687	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.6e-05	0.000685	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	5.5e-05	0.000673	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FGF2—gestational diabetes	5.36e-05	0.000656	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGCT—gestational diabetes	5.31e-05	0.000649	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	5.28e-05	0.000646	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGCT—gestational diabetes	5.26e-05	0.000643	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GLS2—gestational diabetes	5.04e-05	0.000617	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.02e-05	0.000614	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NAMPT—gestational diabetes	4.99e-05	0.00061	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GCK—gestational diabetes	4.96e-05	0.000606	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NAMPT—gestational diabetes	4.94e-05	0.000605	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NAMPT—gestational diabetes	4.94e-05	0.000604	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MTNR1B—gestational diabetes	4.93e-05	0.000602	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GLS2—gestational diabetes	4.92e-05	0.000602	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GCK—gestational diabetes	4.91e-05	0.000601	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GCK—gestational diabetes	4.91e-05	0.0006	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RBP4—gestational diabetes	4.8e-05	0.000587	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NAMPT—gestational diabetes	4.79e-05	0.000586	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GCK—gestational diabetes	4.76e-05	0.000582	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GLS2—gestational diabetes	4.64e-05	0.000567	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NAMPT—gestational diabetes	4.6e-05	0.000563	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GLS2—gestational diabetes	4.6e-05	0.000562	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GCK—gestational diabetes	4.57e-05	0.000559	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.51e-05	0.000551	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGCT—gestational diabetes	4.5e-05	0.00055	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGF2—gestational diabetes	4.41e-05	0.00054	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—LEP—gestational diabetes	4.36e-05	0.000534	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGF2—gestational diabetes	4.24e-05	0.000518	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.11e-05	0.000503	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GLS2—gestational diabetes	3.93e-05	0.000481	CbGpPWpGaD
Imatinib—KIT—Immune System—FGF2—gestational diabetes	3.76e-05	0.000459	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—gestational diabetes	3.7e-05	0.000452	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CYP19A1—gestational diabetes	3.62e-05	0.000443	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CYP19A1—gestational diabetes	3.59e-05	0.000439	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CYP19A1—gestational diabetes	3.59e-05	0.000439	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NAMPT—gestational diabetes	3.57e-05	0.000437	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGF2—gestational diabetes	3.56e-05	0.000435	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GCK—gestational diabetes	3.55e-05	0.000434	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.51e-05	0.00043	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CYP19A1—gestational diabetes	3.48e-05	0.000426	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGCT—gestational diabetes	3.47e-05	0.000424	CbGpPWpGaD
Imatinib—KIT—Disease—FGF2—gestational diabetes	3.47e-05	0.000424	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.41e-05	0.000417	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CYP19A1—gestational diabetes	3.34e-05	0.000409	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF2—gestational diabetes	3.32e-05	0.000405	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF2—gestational diabetes	3.28e-05	0.000402	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF2—gestational diabetes	3.2e-05	0.000392	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—LEP—gestational diabetes	3.2e-05	0.000391	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF2—gestational diabetes	3.12e-05	0.000382	CbGpPWpGaD
Imatinib—ALB—Metabolism—NAMPT—gestational diabetes	3.08e-05	0.000376	CbGpPWpGaD
Imatinib—ALB—Metabolism—GCK—gestational diabetes	3.06e-05	0.000374	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.03e-05	0.000371	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	3.03e-05	0.00037	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF2—gestational diabetes	2.96e-05	0.000362	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NAMPT—gestational diabetes	2.76e-05	0.000338	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GCK—gestational diabetes	2.75e-05	0.000336	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	2.73e-05	0.000334	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NAMPT—gestational diabetes	2.7e-05	0.00033	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GCK—gestational diabetes	2.68e-05	0.000328	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	2.6e-05	0.000318	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF2—gestational diabetes	2.57e-05	0.000314	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.54e-05	0.000311	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GCK—gestational diabetes	2.53e-05	0.000309	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.52e-05	0.000308	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GCK—gestational diabetes	2.5e-05	0.000306	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF2—gestational diabetes	2.43e-05	0.000297	CbGpPWpGaD
Imatinib—LCK—Disease—FGF2—gestational diabetes	2.37e-05	0.00029	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	2.3e-05	0.000281	CbGpPWpGaD
Imatinib—ALB—Metabolism—CYP19A1—gestational diabetes	2.24e-05	0.000274	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LEP—gestational diabetes	2.19e-05	0.000268	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.15e-05	0.000263	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GCK—gestational diabetes	2.14e-05	0.000262	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.07e-05	0.000253	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	2.01e-05	0.000246	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CYP19A1—gestational diabetes	1.96e-05	0.00024	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.85e-05	0.000226	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.83e-05	0.000224	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF2—gestational diabetes	1.66e-05	0.000203	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.66e-05	0.000203	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCK—gestational diabetes	1.65e-05	0.000202	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.56e-05	0.000191	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.21e-05	0.000148	CbGpPWpGaD
